RE:Bud/OfferPeople are tired of the CEO leading them along with a carrot on a string. I strongly believe he is either unable to finish the trial or they know the results are sh1t. It's the only thing that can explain the stalling and change of focus from the completion of the trial to dodging questions about it and proposing we start multiple new trials. Complete reversal in game plan. What used to be talk of commercializing in Asia has been completely ditched. But still he tells us it will be complete this year when he knows it wont to keep his few remaining holders hooked. Maybe i'm wrong but that's how this looks to me. He's also spoken recently about a business opportunity that will allow us to run multiple trials in parallel. That would be an enormous investment and seems like another carrot on a stick to me but who knows. Good luck fellas. Stay tuned for more nothing would be my guess